No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase I
-
Clinical Trial, Phase II
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Boronic Acids / administration & dosage
-
Bortezomib
-
Humans
-
Melphalan / administration & dosage
-
Multiple Myeloma / drug therapy*
-
Neoplasm Recurrence, Local / drug therapy*
-
Prognosis
-
Prospective Studies
-
Pyrazines / administration & dosage
-
Safety
-
Treatment Outcome
Substances
-
Boronic Acids
-
Pyrazines
-
Bortezomib
-
Melphalan